Kashyap, Vivek Wang, Qinghui Setua, Saini Nagesh, Prashanth Chauhan, Neeraj Kumari, Sonam Chowdhury, Pallabita Miller, Duane Yallapu, Murali Li, Wei Jaggi, Meena Hafeez, Bilal Chauhan, Subhash Additional file 1: of Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer Figure S1. (A) Synthesis and chemical structure of VERU-111. (B) 1H NMR characterization of VERU-111 using CD2Cl2 as the NMR solvent and full assignment of proton chemical shifts of VERU-111 (EtOAC: ethyl acetate). Spectrum was acquired on a Bruker Advance III 400 MHz NMR spectrometer equipped with a BBO probe at room temperature. (TIF 1059 kb) VERU-111;Pancreatic cancer;β –tubulins;miR-200c;βIII/βIV-tubulin inhibitor 2019-01-23
    https://springernature.figshare.com/articles/figure/Additional_file_1_of_Therapeutic_efficacy_of_a_novel_III_IV-tubulin_inhibitor_VERU-111_in_pancreatic_cancer/7622996
10.6084/m9.figshare.7622996.v1